Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants.

Twenty-four infants 5 to 13 months of age were intranasally vaccinated with a live cold-recombinant influenza A/Korea (CR-59, H3N2) virus vaccine. Nineteen infants served as controls. The inocula ranged from 10(3.2) to 10(6.2) 50% tissue culture infective doses (TCID50) per infant. Zero of six, one...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Microbiol
Principais autores:	Anderson, E L, Belshe, R B, Burk, B, Bartram, J, Maassab, H F
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC267453/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2745699/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.27.5.909-914.1989
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!